PathPresenter, a pioneer in the development of digital pathology software, and 4D Path Inc., developer of a pan-cancer diagnostic and precision oncology platform enabling AI-based biomarker typing and ...
Proscia (R), a software company advancing digital pathology for pathologists, scientists, and patients, has been awarded Global 2026 Best in KLAS for Digital Pathology (Europe), a top distinction for ...
The transition from conventional microscopy to whole-slide imaging and digital platforms is reshaping pathology practices. Hospitals and laboratories are investing in digital pathology systems to ...
DUBLIN--(BUSINESS WIRE)--The "Global Digital Pathology Growth Opportunities" report has been added to ResearchAndMarkets.com's offering. The global study provides a detailed analysis of digital ...
TUCSON, Ariz., Oct. 26, 2023 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today collaborations with Ibex Medical Analytics and Amazon Web Services, enabling pathology laboratories to ...
PORTSMOUTH, N.H. & KALAMAZOO, Mich.--(BUSINESS WIRE)--Epredia, a global leader in precision cancer diagnostics and subsidiary of PHC Holdings Corporation (TSE: 6523), today announced U.S. Food and ...
Proscia to showcase digital pathology software, image analysis capabilities at 2017 MedCity CONVERGE
Proscia Inc., a software solutions provider for digital pathology, announced today its CEO David West Jr. will be a featured panelist at 2017 MedCity CONVERGE. His talk, “The Davids vs. the Cancer ...
Scientists from Weill Cornell Medicine and the Dana-Farber Cancer Institute in Boston have developed and tested new artificial intelligence (AI) tools tailored to digital pathology—a rapidly growing ...
Pharmaceutical and diagnostics giant Roche has recently integrated a suite of AI algorithms into its enterprise digital pathology software. The company has collaborated with South Korean firm Deep Bio ...
NEW YORK, July 31, 2024 /PRNewswire/ -- The global digital pathology market size is estimated to grow by USD 1.12 billion from 2024-2028, according to Technavio. The market is estimated to grow at a ...
Roche's (RHHBY) navify Digital Pathology software platform now offers Ibex's Artificial Intelligence (AI) algorithms to support clinicians in the diagnosis of breast and prostate cancer. Roche and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results